Participants:18–64 years · 65+ years
Substances:1-[[(5R)-2-[4-(5-Chloro-2-Pyrimidinyl)-1-Piperidinyl]-6,7- Dihydro-5-Oxidothieno[3,2-D]Pyrimidin-4- Yl]Amino]-Cyclobutanemethanol

Contact Research Centre

Primary biliary cholangitis

Not recruiting

InvestigationalNo placebo

Study on the Long-Term Safety of Obeticholic Acid and Bezafibrate for Patients with Primary Biliary Cholangitis

InvestigationalNo placebo

Norway

Participants:18–64 years · 65+ years
Substances:Bezafibrate

Contact Research Centre

Cholangitis sclerosing

Not recruiting

InvestigationalNo placebo

Study on the Safety and Tolerability of Norucholic Acid Tablets for Patients with Primary Sclerosing Cholangitis (PSC)

InvestigationalNo placebo

Norway

Participants:18–64 years · 65+ years
Substances:Norucholic Acid

Contact Research Centre

Colitis ulcerative

Not recruiting

Investigational

Study on the Effects of Zasocitinib for Patients with Moderate to Severe Ulcerative Colitis

Investigational

Norway

Participants:18–64 years · 65+ years
Substances:Zasocitinib

Contact Research Centre

Embolism venous

Not recruiting

Registered drugNo placebo

Study Comparing Abelacimab and Apixaban for Preventing Blood Clots in Cancer Patients

Registered drugNo placebo

Norway

Participants:18–64 years · 65+ years
Substances:Abelacimab

Contact Research Centre

Embolism venous+1

Not recruiting

Registered drugNo placebo

Study on Abelacimab and Dalteparin for Preventing Blood Clots in Patients with Gastrointestinal or Genitourinary Cancer

Registered drugNo placebo

Norway

Participants:18–64 years · 65+ years
Substances:Abelacimab

Contact Research Centre

Chronic obstructive pulmonary disease

Not recruiting

Investigational

Study on Itepekimab for Former Smokers with Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD)

Investigational

Norway

Participants:18–64 years · 65+ years
Substances:Itepekimab

Contact Research Centre

Idiopathic pulmonary fibrosis+1

Not recruiting

Investigational

Study on BI 1839100 for Reducing Cough in Patients with Idiopathic or Progressive Pulmonary Fibrosis

Investigational

Norway

Participants:18–64 years · 65+ years
Substances:Bi 1839100

Contact Research Centre

Malignant melanoma

Not recruiting

Registered drugNo placebo

Study Comparing Naporafenib and Trametinib Combination to Other Therapies for Patients with Previously Treated Unresectable or Metastatic NRAS Mutant Melanoma

Registered drugNo placebo

Norway

Participants:18–64 years · 65+ years
Substances:Dacarbazine

Contact Research Centre

Transitional cell carcinoma

Not recruiting

Registered drugNo placebo

Study of BT8009 Alone or with Pembrolizumab for Patients with Advanced or Metastatic Bladder Cancer

Registered drugNo placebo

Norway

Participants:18–64 years · 65+ years
Substances:Avelumab

Contact Research Centre

Find therapies in clinical trials near you – page 7

120 trials match your criteria

Chronic obstructive pulmonary disease

Study of Tozorakimab for Patients with Chronic Obstructive Pulmonary Disease Who Have Symptoms and a History of Flare-ups

Idiopathic pulmonary fibrosis

Study on the Effects of CAL101 for Patients with Idiopathic Pulmonary Fibrosis

Interstitial lung disease+1

Study to Test if Nerandomilast (BI 1015550) Helps Patients with Interstitial Lung Disease Related to Rheumatic Diseases

Primary biliary cholangitis

Study on the Long-Term Safety of Obeticholic Acid and Bezafibrate for Patients with Primary Biliary Cholangitis

Cholangitis sclerosing

Study on the Safety and Tolerability of Norucholic Acid Tablets for Patients with Primary Sclerosing Cholangitis (PSC)

Colitis ulcerative

Study on the Effects of Zasocitinib for Patients with Moderate to Severe Ulcerative Colitis

Embolism venous

Study Comparing Abelacimab and Apixaban for Preventing Blood Clots in Cancer Patients

Embolism venous+1

Study on Abelacimab and Dalteparin for Preventing Blood Clots in Patients with Gastrointestinal or Genitourinary Cancer

Chronic obstructive pulmonary disease

Study on Itepekimab for Former Smokers with Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD)

Idiopathic pulmonary fibrosis+1

Study on BI 1839100 for Reducing Cough in Patients with Idiopathic or Progressive Pulmonary Fibrosis

Malignant melanoma

Study Comparing Naporafenib and Trametinib Combination to Other Therapies for Patients with Previously Treated Unresectable or Metastatic NRAS Mutant Melanoma

Transitional cell carcinoma

Study of BT8009 Alone or with Pembrolizumab for Patients with Advanced or Metastatic Bladder Cancer

Explore other searches

Vaccine trials

Paediatric trials · ages 0–17

Healthy volunteers

Helpful resources

How applying through us works

What happens after you apply

Guides for patients and volunteers

Search filters

Prefer not to search? Our Concierge searches the trials for you.